Facilities

Helping to meet demands and reduce shortages... Is continuous manufacturing the way forward for pharma?

ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.

If cell and gene therapy products are to successfully reach patients, then the industry will need more facilities capable of manufacturing them.

Eva decides to sort out her bioburden issues after a disturbing dream...

Proactive stress testing is a must to keep facilities fit and healthy.

Eva and Gene discover the perks of modular manufacturing.

Replacing a fumigation system? As a former site fumigation lead, here is how I would go about it.

We need more vaccine manufacturing techniques at our disposal.

Hygiene is essential to pharma, but there are a suprising number of ways it can go wrong.

We track the rapid rise of single use systems – and explore their role in the biomanufacturing facility of the future